Newbridge Financial Services Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.8K | Sell |
|
|||||
|
2025
Q1 | $270K | Buy |
|
|||||
|
2024
Q4 | $56.7K | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $77.9K | Sell |
|
|||||
|
2024
Q1 | $104K | Buy |
|
|||||
|
2023
Q4 | $86.9K | Sell |
|
|||||
|
2023
Q3 | $153K | Sell |
|
|||||
|
2023
Q2 | $170K | Sell |
|
|||||
|
2023
Q1 | $193K | Sell |
|
|||||
|
2022
Q4 | $206K | Buy |
|
|||||
|
2022
Q3 | $118K | Buy |
|
|||||
|
2022
Q2 | $126K | Sell |
|
|||||
|
2022
Q1 | $127K | Buy |
|
|||||
|
2021
Q4 | $104K | Sell |
|
|||||
|
2021
Q3 | $100K | Sell |
|
|||||
|
2021
Q2 | $139K | Sell |
|
|||||
|
2021
Q1 | $141K | Sell |
|
|||||
|
2020
Q4 | $152K | Sell |
|
|||||
|
2020
Q3 | $160K | Buy |
|